Systematic review: the efficacy of herbal therapy in inflammatory bowel disease (Q27004516)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Systematic review: the efficacy of herbal therapy in inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

8 March 2020

main subject

0 references

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Y T Lam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

K K F Tsoi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J C Y Wu

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

1 reference

25 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

8 March 2020

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

854-863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

Review article: understanding adherence to medication in ulcerative colitis – innovative thinking and evolving concepts

8 March 2020

cites work

1 reference

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease

21 January 2018

1 reference

Use of complementary and alternative medicine by patients with inflammatory bowel disease.

21 January 2018

1 reference

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease

21 January 2018

1 reference

Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).

21 January 2018

1 reference

The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products

21 January 2018

1 reference

Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease

21 January 2018

1 reference

Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey

21 January 2018

1 reference

Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients

21 January 2018

1 reference

Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey

21 January 2018

1 reference

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients

21 January 2018

1 reference

Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics

21 January 2018

1 reference

Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis

21 January 2018

1 reference

Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study

21 January 2018

1 reference

Effects of gum resin of Boswellia serrata in patients with chronic colitis

21 January 2018

1 reference

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)

21 January 2018

1 reference

Andrographis paniculata extract (HMPL-004) for active ulcerative colitis

21 January 2018

1 reference

Comparison of Xilei-san, a Chinese herbal medicine, and dexamethasone in mild/moderate ulcerative proctitis: a double-blind randomized clinical trial

21 January 2018

1 reference

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey

21 January 2018

1 reference

Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic?

21 January 2018

1 reference

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey

21 January 2018

1 reference

Use of complementary therapies by patients with IBD may indicate psychosocial distress.

21 January 2018

1 reference

Review article: complementary and alternative therapies for inflammatory bowel disease

21 January 2018

1 reference

Alternative therapy bias.

21 January 2018

1 reference

Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12464

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23981095%20AND%20SRC:MED&resulttype=core&format=json